Meiji Holdings Aims at Sales of 180 Billion Yen and 30% Overseas Sales Ratio in Pharma Business by FY2017

Meiji Holdings President Masahiko Matsuo Meiji Holdings aims to increase sales to 180 billion yen and operating profit to 14 billion yen by FY2017 in its pharmaceuticals business. Under the company’s midterm management plan for FY2015 through FY2017 announced on...read more